At LogicBio, we are committed to delivering genetic medicine to pediatric patients with rare diseases.
We are initially targeting rare liver disorders where it is critically important to treat patients early in life, before irreversible damage occurs. We believe our foundational platform technology,
GeneRide, is well-suited to this goal because – unlike traditional gene therapy – it harnesses the cell’s natural DNA repair process to integrate a corrective gene directly into the patient’s chromosomes. This approach is designed to provide a durable therapeutic benefit from a single treatment.
Our team is comprised of global leaders in gene therapy and gene editing.
We are passionate, driven and fiercely committed to developing the next generation of genetic medicines.
We are here to make a difference.
©2023 LOGICBIO THERAPEUTICS, INC. Privacy Policy | Terms of Use